This interaction between nuclear methylation and HIF1 signaling was also demonstrated to occur via FAD (vitamin B2) regulation of KDM1A, where FAD regulated HIF1A stability in a KDM1-dependent fashion in cancer cells (Yang et al., 2017). The gene discussed is KDM1A; the disease is cancer.